Role of melatonin in cancer treatment
- PMID: 22753734
Role of melatonin in cancer treatment
Abstract
Melatonin has revealed itself to be a pleiotropic and multitasking molecule. The mechanisms that control its synthesis and the biological clock processes that modulate the circadian production of melatonin in the pineal gland have been well-characterized. A feature that characterizes melatonin is the variety of mechanisms it employs to modulate the physiology and molecular biology of cells. Research has implicated the pineal gland and melatonin in the processes of both aging and age-related diseases. The decline in the production of melatonin with age is thought to contribute to immunosenescence and potential development of neoplastic diseases. Melatonin has been shown to inhibit growth of different tumors under both in vitro and in vivo conditions. There is evidence that the administration of melatonin alone or in combination with interleukin-2 in conjunction with chemoradiotherapy and/or supportive care in cancer patients with advanced solid tumors, has been associated with improved outcomes of tumor regression and survival. Moreover, chemotherapy has been shown to be better tolerated in patients treated with melatonin.
Similar articles
-
Melatonin: a multitasking molecule.Prog Brain Res. 2010;181:127-51. doi: 10.1016/S0079-6123(08)81008-4. Prog Brain Res. 2010. PMID: 20478436 Review.
-
Is there a role for melatonin in supportive care?Support Care Cancer. 2002 Mar;10(2):110-6. doi: 10.1007/s005200100281. Epub 2001 Nov 13. Support Care Cancer. 2002. PMID: 11862501 Review.
-
[Significance of melatonin in malignant diseases].Wien Klin Wochenschr. 1997 Oct 3;109(18):722-9. Wien Klin Wochenschr. 1997. PMID: 9441515 Review. German.
-
Melatonin in clinical oncology.Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:30-8. Neuro Endocrinol Lett. 2002. PMID: 12019349 Review.
-
Melatonin in cancer management: progress and promise.Cancer Res. 2006 Oct 15;66(20):9789-93. doi: 10.1158/0008-5472.CAN-06-1776. Cancer Res. 2006. PMID: 17047036 Review.
Cited by
-
Melatonin: an anti-tumor agent for osteosarcoma.Cancer Cell Int. 2019 Nov 29;19:319. doi: 10.1186/s12935-019-1044-2. eCollection 2019. Cancer Cell Int. 2019. PMID: 31798348 Free PMC article. Review.
-
Melatonin modulates L-arginine metabolism in tumor-associated macrophages by targeting arginase 1 in lymphoma.Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):1163-1179. doi: 10.1007/s00210-023-02676-2. Epub 2023 Aug 28. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37639022
-
Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms.Int J Biol Sci. 2021 Aug 27;17(14):3728-3744. doi: 10.7150/ijbs.62280. eCollection 2021. Int J Biol Sci. 2021. PMID: 34671196 Free PMC article.
-
Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.Mol Neurobiol. 2015 Aug;52(1):330-40. doi: 10.1007/s12035-014-8865-8. Epub 2014 Aug 27. Mol Neurobiol. 2015. PMID: 25159482 Review.
-
Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.Oncol Lett. 2016 Jul;12(1):231-237. doi: 10.3892/ol.2016.4605. Epub 2016 May 18. Oncol Lett. 2016. PMID: 27347130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources